Multimodality Treatment of HFrEF: From Device Therapy to M-TEER

31 August 2026 (08:17 - 08:31)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Riza Salim

Institute of Cardiovascular Diseases Prof. C.C. Iliescu, Bucharest (Romania)

4 More presentations in this session

Presentation thumbnail

Clinical cases of guideline-direct therapy for tricuspid and mitral valve disease - get ready for the session

Doctor A. Sorropago (Monza, IT)

Presentation thumbnail

Left ventricular outflow tract obstruction after mechanical mitral valve replacement caused by anterior papillary muscle interposition

Doctor A. Chikovani (Tbilisi, GE)

Presentation thumbnail

Unexplained hypoxemia in carcinoid heart disease: when TR takes an unexpected direction

Doctor R. Wimolwattanaphan (Bangkok, TH)

Presentation thumbnail

Transcatheter treatment of torrential tricuspid regurgitation using a novel spacer device

Doctor A. Moussad (Sydney, AU)

Access the full session

Session thumbnail

Clinical cases of guideline-directed therapy for tricuspid and mitral valve disease

The Event

Event poster

ESC Congress 2026

31 August 2026 08:17 CET

You may be interested in

Congress Session

Navigating through heart failure device therapies

18 May 2025

Congress Presentation

The implementation of modern guideline-directed medical therapy among hospitalized patients with heart failure with reduced ejection fraction: real-world experience from two tertiary cardiac centers

30 August 2024

Congress Session

Heart failure management: cardiac resynchronisation therapy and guideline-directed medical therapy synergy

29 August 2026

Webinar

Chronic coronary syndrome post-myocardial infarction: disease progression and comorbidities

30 October 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources